| Name | 4-(4,5-dihydro-1H-imidazol-2-yl)aniline |
|---|---|
| Synonyms |
2-(4-aminophenyl)-4,5-dihydro-1H-imidazole
4-(4,5-dihydro-1H-imidazol-2-yl)-benzenamine 4-(4,5-dihydro-1H-imidazol-2-yl)-aniline 4-(4,5-Dihydro-1H-imidazol-2-yl)phenylamine 4-(4,5-Dihydro-1H-imidazol-2-yl)-anilin 2-Imidazoline,2-(p-aminophenyl) |
| Melting Point | 145-149 °C |
|---|---|
| Molecular Formula | C9H11N3 |
| Molecular Weight | 161.20400 |
| Exact Mass | 161.09500 |
| PSA | 50.41000 |
| LogP | 0.96420 |
|
~53%
61033-71-4 |
| Literature: Wydra, Roman L.; Patterson, Steven E.; Strekowski, Lucjan Journal of Heterocyclic Chemistry, 1990 , vol. 27, # 3 p. 803 - 805 |
|
~%
61033-71-4 |
| Literature: Pfizer and Co. Patent: DE1015805 , 1955 ; Full Text Show Details Sahyun Labor. Patent: US2733244 , 1954 ; |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |